| Breanne Aird, MSOT, OTR/L | |
|
1810 Chartwell Dr, Traverse City, MI 49696-9283 | |
| (231) 929-2354 | |
| (231) 929-2853 |
| Full Name | Breanne Aird |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 1810 Chartwell Dr, Traverse City, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275224271 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 5201013386 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Breanne Aird, MSOT, OTR/L 610 N 8th St, Gladstone, MI 49837-1114 Ph: (906) 553-2990 | Breanne Aird, MSOT, OTR/L 1810 Chartwell Dr, Traverse City, MI 49696-9283 Ph: (231) 929-2354 |
News Archive
Cardinal Health today announced plans to acquire The Harvard Drug Group (THDG), a distributor of generic pharmaceuticals, over-the-counter medications and related products to retail, institutional and alternate care customers.
Older individuals and those with chronic conditions are especially at risk following natural disasters.
Which antiplatelet medication is best after a coronary stent? The Tailored Antiplatelet Therapy to Lessen Outcomes After Percutaneous Coronary Intervention (TAILOR-PCI) Study examines whether prescribing heart medication based on a patient's CYP2C19 genotype will help prevent heart attack, stroke, unstable angina, and cardiovascular death in patients who undergo percutaneous coronary intervention (PCI), commonly called angioplasty.
Baylor Endocrine Center is looking for volunteers to take part in a study to compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes. The project is called the GRADE: Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study.
Specialty pharmaceutical company Hatchtech Pty Ltd today announced positive results for its Phase 2b clinical trial in subjects with head lice infestation. The results confirmed that DeOvo, a topical head lice treatment, is both safe and highly effective following a single application.
› Verified 1 days ago
Kristine A Siemer, OTR/L, CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1105 Sixth St, Traverse City, MI 49684 Phone: 231-935-8600 | |
Susan Milliman, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1650 Barlow St Ste 11, Traverse City, MI 49686 Phone: 231-941-3100 Fax: 231-922-0382 | |
Hannah Schweikart, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1000 Pavillions Cir, Traverse City, MI 49684 Phone: 231-932-3000 | |
Stacey Karpouzes Mower, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1650 Barlow St Ste 10, Traverse City, MI 49686 Phone: 231-941-8100 | |
Ms. Michelle Sturdevant, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2950 Lafranier Rd, Traverse City, MI 49686 Phone: 231-947-0506 | |
Samuel Olsen Olsen, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1810 Chartwell Dr, Traverse City, MI 49696 Phone: 231-929-2354 | |
Barbara Jeanne Martin, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1650 Barlow St, Traverse City, MI 49686 Phone: 231-941-4100 Fax: 231-922-0382 |